natgillin/translations-raw huggingface dataset:
• An infection or a fever
• Imate okužbo ali zvišano telesno temperaturo.
Solution for injection or infusion in a vial.
Raztopina za injiciranje ali infundiranje v viali.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or pharmacist.
e kateri koli neželeni u inek postane resen ali e opazite katerikoli neželeni u inek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika, diabetološko sestro ali farmacevta.
Patients whose blood glucose control is greatly improved e.g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia and should be advised accordingly.
Bolnikom, ki se jim uravnanost glukoze v krvi zelo izboljša, npr. z intenziviranim insulinskim zdravljenjem, se obi ajni opozorilni simptomi hipoglikemije lahko spremenijo in jih je s to možnostjo treba seznaniti.
Generalised hypersensitivity reactions are potentially lifethreatening.
Generalizirane preob utljivostne reakcije so lahko smrtno nevarne.
In clinical trials and during marketed use, the frequency varies with patient population and dose regimens.
Pogostnost v klini nih raziskavah in med uporabo, ko je insulin že na trgu, se spreminja glede na populacijo bolnikov in odmerne sheme.
Concerning compatibility with insulin infusion pumps, reservoirs, catheters and needles, see section
O združljivosti z insulinskimi infuzijskimi rpalkami, rezervoarji, katetri in iglami glejte poglavje 6.6.
The patient should follow the instructions from the physician about the basal infusion rate and the mealtime insulin boluses to be taken.
Bolnik mora upoštevati zdravnikova navodila o hitrosti bazalne infuzije in bolusih insulina, ki jih mora uporabiti ob obrokih.
Insulin treatment of the nursing mother presents no risk to the baby.
Zdravljenje doje e matere z insulinom ne pomeni nobene nevarnosti za dojen ka.
Your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (MAOI); beta-blockers; ACE-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; betasympathomimetics; growth hormone; danazol; octreotide or lanreotide.
Vaša potreba po insulinu se lahko spremeni, e uporabljate tudi: peroralne antidiabetike; zaviralce monoaminooksidaze (MAOI); zaviralce beta; zaviralce ACE; acetilsalicilno kislino; anabolne steroide; sulfonamide; peroralne kontraceptive; tiazide; glukokortikoide; zdravljenje s šitninimi hormoni; beta-simpatikomimetike; rastni hormon; danazol; oktreotid ali lanreotid.
A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels.
Nepravilno delovanje rpalke ali zamašitev infuzijskega kompleta lahko povzro i hitro zvišanje koncentracije glukoze v krvi.
Seek medical advice after an injection of glucagon; you need to find the reason for your hypo to avoid getting more.
Po injekciji glukagona poiš ite zdravniško pomo : ugotoviti morate razlog za hipo, da jih ne boste doživeli še ve .
Intravenous administration should only be carried out by health care professionals.
Intravensko aplikacijo lahko izvede le medicinsko osebje.
• Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
• Blage hipoglikemije je mogo e zdraviti z zaužitjem glukoze ali sladkih izdelkov.
If you get any of these signs, eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest.
e se pojavi kateri od teh znakov, zaužijte tablete glukoze ali prigrizek, ki vsebuje veliko sladkorja (bonbone, piškote, sadni sok), in nato po ivajte.
Uncommon - Urticaria, rash
Ob asni - urtikarija, izpuš aj
After first use as infusion: the insulin solution may be stored in the pump reservoir at up to 37°C (close to the body).
Po prvi uporabi v infuziji: raztopina insulina lahko ostane v rezervoarju rpalke pri temperaturi do 37 °C (blizu telesa).
Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Dolgoro no izboljšana urejenost glikemije zmanjša tveganje za napredovanje diabeti ne retinopatije.
Velosulin may also be administered intravenously in special situations by medical professionals.
Intravensko aplikacijo zdravila Velosulin lahko v posebnih primerih izvede le medicinsko osebje.
Beta-blocking agents may mask the symptoms of hypoglycaemia and delay recovery from hypoglycaemia.
Zaviralci beta lahko prikrijejo simptome hipoglikemije in upo asnijo okrevanje po njej.
When filling a new syringe, no large air bubbles should be left in either the syringe or the catheter.
Pri polnitvi nove brizge ne sme ne v brizgi ne v katetru ostati velikih zra nih mehur kov.
Velosulin should not be mixed with insulin zinc suspensions since the phosphate buffer may interact with the zinc in the suspension and alter the timing of action of the insulin in an unpredictable way.
Zdravila Velosulin se ne sme mešati s suspenzijami insulina s cinkom, ker lahko fosfatni pufer reagira s cinkom v suspenziji, kar nepredvidljivo spremeni asovni potek delovanja insulina.
The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.
Delovanje insulina na znižanje glukoze v krvi je posledica lažjega prehoda glukoze zaradi vezave insulina na receptorje na miši nih in maš obnih celicah ter hkratne inhibicije sproš anja glukoze iz jeter.
Solusion for injection or infusion 5 x (1 x 10 ml)
Raztopina za injiciranje ali infundiranje 5 x (1 x 10 ml)
Follow the instructions and recommendations from your doctor regarding the use of Velosulin in a pump.
Upoštevajte zdravnikova navodila in priporo ila o uporabi zdravila Velosulin v rpalki.
Octreotide/lanreotide may both decrease and increase insulin requirement.
Oktreotid/lanreotid lahko potrebo po insulinu zmanjša ali zve a.
Before use: store in a refrigerator (2°C - 8°C).
Pred uporabo: shranjujte v hladilniku (med 2 °C in 8 °C)!
This phosphate-buffered soluble insulin is intended for continuous subcutaneous insulin infusion (CSII) in external insulin infusion pumps.
S fosfatom pufrani topni insulin je namenjen za stalno subkutano infuzijo insulina v zunanjih insulinskih infuzijskih rpalkah.
Therefore, no specific frequency can be presented.
Natan ne pogostnosti ni mogo e navesti.
You can keep it in the pump reservoir for 6 days at up to 37°C (close to the body).
V rezervoarju rpalke lahko imate zdravilo 6 dni pri temperaturi do 37°C (v bližini telesa).
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.
Neklini ni podatki na podlagi obi ajnih študij farmakološke varnosti, toksi nosti pri ponavljajo ih odmerkih, genotoksi nosti, kancerogenega potenciala in vpliva na sposobnost razmnoževanja ne kažejo posebnega tveganja za ljudi.
Eat a meal or snack containing carbohydrates within 30 minutes of administration.
V 30 minutah po uporabi pojejte obrok ali prigrizek, ki vsebuje ogljikove hidrate.
Uncommon - Peripheral neuropathy
Ob asni - periferna nevropatija
Continuous subcutaneous insulin infusion (CSII) in external insulin infusion pumps is usually administered in the abdominal wall.
Stalna subkutana infuzija insulina v zunanjih rpalkah za infundiranje insulina se ponavadi aplicira v trebušno steno.
Name and address of the manufacturer of the biological active substance
Ime in naslov izdelovalca biološke zdravilne u inkovine
A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION
A. IZDELOVALEC BIOLOŠKE ZDRAVILNE U INKOVINE IN IMETNIKI DOVOLJENJA ZA IZDELAVO ZDRAVILA,
Each vial has a protective, tamper-proof plastic cap.
Vsaka viala ima zaš itno, varovalno plasti no zaporko.
However, intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy.
Vendar lahko intenziviranje insulinskega zdravljenja s hitrim izboljšanjem urejenosti glikemije spremlja prehodno poslabšanje diabeti ne retinopatije.
Solusion for injection or infusion 1 x 10 ml
Raztopina za injiciranje ali infundiranje 1 x 10 ml
They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath.
Vklju ujejo žejo, pogostejše uriniranje, navzejo, bruhanje, zaspanost, pordelo suho kožo, suha usta, izgubo apetita in acetonski zadah.
In patients with diabetes mellitus optimised glycaemic control delays the onset of late diabetic complications.
im boljša glikemi na urejenost pri bolnikih z diabetesom mellitusom odloži nastanek poznih diabetinih zapletov.
The terminal half-life is determined by the rate of absorption from the subcutaneous tissue.
Terminalni razpolovni as je dolo en s hitrostjo absorpcije iz podkožnega tkiva.
Oral hypoglycaemic agents (OHA), monoamine oxidase inhibitors (MAOI), non-selective betablocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids or sulphonamides.
Peroralni antidiabetiki, zaviralci monoaminoksidaze (MAOI), neselektivni zaviralci adrenergi nih receptorjev beta, zaviralci angiotenzinske konvertaze (ACE), salicilati, alkohol, anabolni steroidi in sulfonamidi.
Glycerol
OVOJNINAH
PARTICULARS TO APPEAR ON THE PACKAGING OUTER WRAPPER LABLE ON MULTIPACKS
PODATKI NA OVOJNINI NALEPKA ZUNANJEGA OVOJA MULTIPLIH PAKIRANJ
Due to the lack of long-acting insulin, patients receiving continuous subcutaneous insulin infusion via an insulin pump are at risk of fast development of ketoacidosis in case of prolonged interruption of continuous subcutaneous insulin infusion.
Zaradi odsotnosti dolgodelujo ega insulina bolnike, ki dobivajo stalno subkutano infuzijo insulina z insulinsko rpalko, ogroža hiter nastanek ketoacidoze, e je stalno subkutano infundiranje insulina dalj asa prekinjeno.
Patients using CSII may be more prone to infection at the site of infusion.
Bolniki, ki uporabljajo stalno subkutano infuzijo insulina, so lahko bolj nagnjeni k okužbi na infuzijskem mestu.
After first use as infusion, the insulin solution may be stored in the pump reservoir for six days at up to 37°C (close to the body).
Po prvi uporabi v infuziji lahko raztopina insulina ostane v rezervoarju rpalke šest dni pri temperaturi do 37 °C (blizu telesa).
What Velosulin contains
Kaj vsebuje zdravilo Velosulin
The thigh, the gluteal region or the deltoid region may also be used.
Uporabiti pa je mogo e tudi stegno, glutealni predel ali deltoidni predel.
Novo Allé, DK-2880 Bagsværd, Denmark
Novo Nordisk A/S Novo Allé, DK-2880 Bagsværd, Danska
WHAT VELOSULIN IS AND WHAT IT IS USED FOR Velosulin is human insulin to treat diabetes.
Velosulin je humani insulin za zdravljenje diabetesa.
Upon mixing Velosulin with infusion fluids an unpredictable amount of insulin will be absorbed to the infusion material.
Po mešanju Velosulina s teko inami za infundiranje se nepredvidljiva koli ina insulina adsorbira na infuzijski material.
Always vary the sites you inject, to avoid lumps (see 5 Possible side effects).
Mesta injiciranja vedno menjajte, da boste prepreili nastanek zatrdlin (glejte poglavje 5.
When two types of insulin are mixed, draw the amount of fast-acting insulin first, followed by the amount of long-acting insulin.
V primeru mešanja dveh vrst insulinov je najprej treba izvle i odmerek hitrodelujo ega insulina in potem odmerek dolgodelujo ega insulina.
If the patient suspects an interruption to insulin flow the patient should notify the health care professional.
e bolnik posumi, da je dotok insulina prekinjen, mora obvestiti zdravnika.
Both hypoglycaemia and hyperglycaemia, which can occur in inadequately controlled diabetes therapy, increase the risk of malformations and death in utero.
Med nezadostno urejenim zdravljenjem diabetesa se lahko pojavita hipoglikemija in hiperglikemija, ki obe zve ujeta tveganje za malformacije in smrt in utero.
Uncommon - Refraction disorders
Ob asni - refrakcijske motnje
When combination with long-acting insulin is necessary it is only possible to mix Velosulin with isophane or premixed insulin products.
e je potrebna kombinacija z dolgodelujo imi insulini, je Velosulin mogo e mešati le z izofanim insulinom ali mešanimi insulini.
Check the label to make sure it is the right type of insulin Disinfect the rubber membrane with a medicinal swab.
Preden uporabite Velosulin preverite nalepko, da se boste prepri ali, ali imate pravo vrsto insulina; dezinficirajte gumijasto membrano z medicinskim zložencem.
If you are pregnant, planning a pregnancy or breast-feeding: please contact your doctor for advice.
Nose nost in dojenje e ste nose i, nameravate zanositi ali dojite: za nasvet prosite svojega zdravnika.
Patients started on CSII must receive comprehensive instruction in the use of the pump, and the necessary actions in case of illness, hypoglycaemia, hyperglycaemia or pump failure.
Bolniki, ki za enjajo zdravljenje s stalno subkutano infuzijo insulina, morajo dobiti iz rpna navodila o uporabi rpalke in potrebnem ukrepanju v primeru bolezni, hipoglikemije, hiperglikemije ali odpovedi rpalke.
Velosulin is administered subcutaneously in the abdominal wall.
Velosulin se subkutano injicira v trebušno steno.
Intensified control in the treatment of pregnant women with diabetes is therefore recommended throughout pregnancy and when contemplating pregnancy.
Zato je pri ženskah z diabetesom med nose nostjo in kadar želijo zanositi priporo ljivo intenzivnejše nadziranje.
It is supplied in packs of 1 or 5 vials of 10 ml or in a multipack of 5 x (1 x 10 ml) vials.
Opremljena v pakiranjih z 1 ali 5 10-ml vialami ali v pakiranjih z ve vialami, v katerih je 5 x (1 x 10 ml) vial (na trgu lahko ni vseh navedenih pakiranj).
Discuss with your doctor whether you can drive or use machines at all, if you have a lot of hypos or if you find it hard to recognise hypos.
Nikdar ne vozite in ne uporabljajte strojev, e utite, da se pojavlja hipa.Z zdravnikom se posvetujte, ali lahko sploh vozite ali upravljate s stroji, e doživljate veliko hip ali hipe težko prepoznate.
Use in syringes
Uporaba v brizgah
They include: increased urination; feeling thirsty; losing your appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed, dry skin; dry mouth and a fruity (acetone) smell of the breath.
Med njimi so: pove ano uriniranje, ob utek žeje, izguba apetita, ob utek slabosti (slabost ali bruhanje), ob utek zaspanosti ali utrujenosti, pordela, suha koža, suha usta in zadah z vonjem po sadju (acetonu).
Medicinal products added to the insulin solution may cause degradation of the insulin, e.g. if the medicinal products contain thiols or sulphites.
Insulinska zdravila je dovoljeno dodajati le snovem, s katerimi so znano kompatibilna.Zdravila, dodana raztopini insulina, lahko povzro ijo razgradnjo insulina, npr. e zdravilo vsebuje tiole ali sulfite.
Always have ordinary syringes available in case of pump interruption or failure.
Vedno imejte na zalogi navadne brizge za primer, da rpalka preneha delovati ali odpove.
Monitoring of the patient's blood glucose during infusion is therefore recommended.
Med infundiranjem je zato priporo ljivo nadziranje bolnikove glukoze v krvi.
4.6 Pregnancy and lactation
4.6 Nose nost in dojenje
MARKETING AUTHORISATION NUMBERS EU/1/02/232/001 1 x 10 ml
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/232/001 1 x 10 ml
If your blood glucose levels improve very fast it may cause a burning, tingling or electric pain.
e se vam koncentracija sladkorja v krvi izboljša zelo hitro, lahko to povzro i peko ob utek, mravljin enje ali elektri ne bole ine.
Velosulin vials are for use with insulin syringes with the corresponding unit scale.
Viale zdravila Velosulin so namenjene uporabi z insulinskimi brizgami, ki imajo ustrezno odmerno skalo.
Refraction anomalies may occur upon initiation of insulin therapy.
Po za etku zdravljenja z insulinom se lahko pojavijo refrakcijske anomalije.
Dosage
Presnova
zinc chloride, glycerol, metacresol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
cinkov klorid, glicerol, metakrezol, natrijev hidrogenfosfat dihidrat, natrijev hidroksid, klorovodikova kislina in voda za injekcije.
Patients administering Velosulin by CSII must have injection syringes and alternative insulin readily available in case of emergency or pump interruption or failure, in order that insulin can be administered by subcutaneous injection.
Bolniki, ki Velosulin uporabljajo v stalni subkutani infuziji, morajo imeti pri roki brizge in drug insulin, e se zgodi, da rpalka preneha delovati ali odpove; tako si lahko insulin aplicirajo s subkutano injekcijo.
When administered by CSII no other medicinal products or other insulin products should be mixed in the reservoir of the infusion pump with Velosulin.
Kadar se Velosulin uporablja v stalni subkutani infuziji, se z njim v rezervoarju infuzijske rpalke ne sme mešati nobenih drugih zdravil ali drugih insulinov.
Disodium phosphate dihydrate Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections
6.1 Seznam pomožnih snovi cinkov klorid glicerol metakrezol natrijev hidrogenfosfat dihidrat natrijev hidroksid (za uravnavo pH) klorovodikova kislina (za uravnavo pH) voda za injekcije
Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia.
Izpustitev obroka ali nena rtovana, naporna telesna dejavnost lahko povzro ita hipoglikemijo.
The vials may be used with insulin syringes with a corresponding unit scale.
Viale so namenjene uporabi z insulinskimi brizgami, ki imajo ustrezno odmerno skalo.
See also warning in 2 Before you use Velosulin.
Kaj morate vedeti, preden boste uporabili Velosulin.
STATEMENT OF ACTIVE SUBSTANCE 1 ml solution contains 100 IU (3.5 mg) of insulin human (rDNA).
NAVEDBA ENE ALI VE ZDRAVILNIH U INKOVIN 1 ml raztopine vsebuje 100 i.e. (3,5 mg) humanega insulina (rDNA),
Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol.
Potrebo po insulinu lahko zve ajo naslednje snovi: peroralni kontraceptivi, tiazidi, glukokortikoidi, š itni ni hormoni, beta-simpatikomimetiki, rastni hormon in danazol.
- The other ingredients are zinc chloride, glycerol, metacresol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
- Pomožne snovi so cinkov klorid, glicerol, metakrezol, dinatrijev fosfat dihidrat, natrijev hidroksid, klorovodikova kislina in voda za injekcije.
MARKETING AUTHORISATION NUMBER(S) EU/1/02/232/003
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/232/003
MARKETING AUTHORISATION NUMBER(S) EU/1/02/232/001-003
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/02/232/001-003
Always keep the vial in the outer carton when you're not using it in order to protect it from light.
Kadar viale ne uporabljate, jo vedno shranjujte v zunanji ovojnini, da bo zaš itena pred svetlobo.
Close blood glucose monitoring is therefore recommended.
Zato je priporoljivo natanno nadzorovanje glukoze v krvi.
Draw air into the syringe, in the same amount as the dose of insulin you need Inject the air into the vial: push the needle through the rubber stopper and press the plunger Turn the vial and syringe upside down
Injicirajte zrak v vialo: potisnite iglo skozi gumijasti zamašek in pritisnite bat.
You get a hypo if your blood sugar gets too low.
Hipa se pojavi, e se sladkor v krvi preve zniža.
Don't take any insulin if you feel a hypo coming on.
e utite, da se pojavlja hipa, si ne dajajte insulina.
6 HOW TO STORE VELOSULIN
SHRANJEVANJE ZDRAVILA VELOSULIN
Follow the instructions of your doctor or diabetes nurse concerning the correct mixing procedure.
Za mešanje zdravila Velosulin z dolgodelujo im insulinom Upoštevajte navodila, ki ste jih za pravilen postopek mešanja dobili od zdravnika ali diabetološke sestre.
Usual warning symptoms may disappear in patients with longstanding diabetes.
Pri bolnikih, ki imajo diabetes že dolgo, lahko obi ajni opozorilni simptomi izginejo.
Velosulin should never be mixed with any other insulin when used in a pump.
e se Velosulin uporablja v rpalki, se ga nikoli ne sme mešati z nobenim drugim insulinom.
Insulin infusion (CSII):
Infundiranje insulina (stalna subkutana infuzija insulina):
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT
POSEBNO OPOZORILO O SHRANJEVANJU ZDRAVILA ZUNAJ DOSEGA IN Zdravilo shranjujte nedosegljivo otrokom!
Carry glucose tablets, sweets, biscuits or fruit juice with you, just in case.
Za vsak primer vedno imejte pri sebi tablete glukoze, bonbone, piškote ali sadni sok.
Keep the vial in the outer carton in order to protect from light.
Vialo shranjujte v zunanji ovojnini za zaš ito pred svetlobo!
If they do not disappear, see your doctor.
e ne minejo, pojdite k zdravniku.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS VIAL LABEL
ŠKATLAPODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STI NIH
PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Izgled zdravila Velosulin in vsebina pakiranja
• If you take too much insulin
• uporabite preve insulina,
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Velosulin 100 IU/ml solution for injection or infusion Insulin human (rDNA)
IME ZDRAVILA IN POT(I) UPORABE Velosulin 100 i.e./ml raztopina za injiciranje ali infundiranje humani insulin (rDNA)
Follow their advice carefully.
Natan no upoštevajte njihova navodila.
What Velosulin looks like and contents of the pack The solution for injection or infusion comes as a clear, colourless, aqueous solution.
Raztopina za injiciranje ali infundiranje je bistra, brezbarvna, vodna raztopina.
Velosulin 100 IU/ml solution for injection in a vial Insulin human (rDNA)
Velosulin 100 i.e./ml raztopina za injiciranje v viali humani insulin (rDNA)
If you notice your skin pitting or thickening at the injection site, tell your doctor or diabetes nurse because these reactions can become more severe, or they may change the absorption of your insulin if you inject in such a site.
Takšne reakcije namre lahko postanejo hujše ali spremenijo absorpcijo insulina, e ga injicirate na takšno mesto.
Injection site reactions (redness, swelling, itching, pain and haematoma at the injection site) may occur during treatment with insulin.
Med zdravljenjem z insulinom se lahko pojavijo reakcije na injekcijskem mestu (pordelost, oteklost, srbenje, bole ine in hematomi na injekcijskem mestu).
Ask your pharmacist how to dispose of medicines no longer required.
O na inu odstranjevanja zdravila, ki ga ne potrebujete ve, se posvetujte s farmacevtom.
EFFECTIVE USE OF THE MEDICINAL PRODUCT Not applicable.
Navedba smiselno ni potrebna.
OUTER CARTON
Izlo anje
Store in a refrigerator (2°C - 8°C) Do not freeze
Shranjujte v hladilniku (med 2 °C in 8 °C)!
Injection into a lifted skin fold minimises the risk of unintended intramuscular injection.
Injiciranje v dvignjeno kožno gubo minimizira tveganje za nenamerno intramuskularno injiciranje.Igla mora ostati pod kožo vsaj 6 sekund, da je zagotovljeno injiciranje celotnega odmerka.
Swollen joints.
Otekli sklepi.
If you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands If you are drinking alcohol: watch for signs of a hypo and never drink alcohol on an empty
Pri uporabi zdravila Velosulin bodite posebej pozorni, e imate težave z ledvicami, jetri, nadledvi no žlezo, hipofizo ali š itnico; pijete alkohol: pazite na znake hipe in alkohola nikdar ne pijte na prazen želodec; ste telesno bolj dejavni kot ponavadi ali želite spremeniti svojo obi ajno prehrano; ste bolni: insulin uporabljajte še naprej; potujete v tujino: potovanje med razli nimi asovnimi pasovi lahko vpliva na potrebe po
Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C May be kept in an infusion pump at up to 37°C for 6 days
Med uporabo: ne shranjujte v hladilniku; hranite pri temperaturi do 25 °C.
See 4 What to do in an emergency for more about hypos.
Za podrobnosti o hipah glejte poglavje 4.